CALGB C80702, A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Digestive System Cancer
This is a clinical trial of celecoxib that will be administered by mouth which is investigational and "FOLFOX"; a combination of 5-flourouracil (also called 5-FU), leucovorin and oxaliplatin that will be administered by IV and is standard of car
IRB Protocol #
DAVID SHENEMAN at (720)848-0286 or DAVID.SHENEMAN@UCDENVER.EDU
Dept Of Veterans Affairs Medical Center University of Colorado Hospital Dept Of Veterans Affairs Medical Center University of Colorado Hospital
Eligibility and Other Participant Information
What To Expect : A screening period to determine eligibility. A treatment period that can last up to 3 years.. A follow up period will consist of phone contact or clinic visit. // Eligibility criteria include but are not limited to 18 years or older with colon cancer that has spread to lymph nodes.Eligibility criteria include but are not limited to 18 years or older with colon cancer that has spread to lymph nodes.